Comparative study of fetomaternal outcome using new screening criteria of serum TSH for diagnosing hypothyroidism in pregnancy

• Main Authors: Shiva Kumar H C Hiriyur Chidanandaiah, Chandrashekhar T Tharihalli, Suman Gaddi, Chandrashekhar K
• Format: Article
• Language: English
• Published: Barpeta Obstetrics and Gynaecological Society 2019-01-01
• Series: New Indian Journal of OBGYN
• Subjects: thyroid disorders; screening in pregnancy; serum tsh; fetal outcome
• Online Access: https://journal.barpetaogs.co.in/pdf/05126.pdf

Objectives: To assess the maternal and fetal outcomes using new screening criteria with upper serum thyroid stimulating hormone (TSH) cut off as >3mIU/L, for diagnosing hypothyroidism in pregnancy. Materials and Methods: This study was a cross sectional study, carried out in the department of Obstetrics and Gynaecology. During one year of study period from February 2016 to January 2017, pregnant women with ≤ 20 weeks gestation, attending antenatal OPD were included in the study and they were followed till delivery. On the basis of serum TSH level, women were divided into study group with serum TSH level between 3.1 to 6 mIU/L, (new range to be studied) and an equal number of ages and parity matched control group with serum TSH levels between 0.4 to 3 mIU/L. The maternal and fetal outcomes were compared between study and control groups. Results: During the study period, in study group 96 women had serum TSH between 3.1-6 mIU/L. Maternal and fetal outcomes in both the groups were comparable. Study did not find any difference in the rate of spontaneous abortion between women in study and control group [p > 0.99]. There was no significant difference in the maternal complications like preeclampsia, gestational diabetes and placental abruption in the study and control group. Vaginal delivery and caesarean section were similar in both the groups. Study shows no significant difference of foetal outcome in study and control group [p > 0.05]. Conclusion: As compared to pregnant women with serum TSH levels <3mIU/L, women with serum TSH levels between 3.1-6.0mIU/L had no significant adverse fetomaternal outcome.